This month we are presenting the annual life science market trend report for Germany that was created thanks to the cooperation with our partners: BIO Deutschland, HEALTH MADE IN GERMANY, Cluster Biotechnology North Rhine-Westphalia, and BioRN.
With about 1,200 active companies, over 500 assets available for licensing and 478 million dollars of venture capital attracted in 2019, German biotech continues to perform extremally well. Also, the medical devices sector that currently consists of 550 companies stays very strong.
Would you like to be notified about new reports and other valuable content published by Biotechgate?